Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: May 2022

Byondis and Medac link up to commercialise trastuzumab duocarmazine

Byondis and Medac have entered into a license and collaboration agreement for form of targeted chemotherapy

May 3, 2022 Uncategorized

Idorsia’s Quviviq approved for adults with chronic insomnia disorder

The EC’s decision on the insomnia treatment was supported by phase 3 trial results

May 3, 2022 Uncategorized

Electronic noses to track down body odors

Human body odor is influenced by diet, inflammatory processes, and hormone balance, among other factors, and consequently changes […]

May 3, 2022 Uncategorized

Decoding the hearing: ERC grant for Tobias Moser

Tobias Moser, MD, Director of the Institute for Auditory Neuroscience at the University Medical Center Göttingen (UMG) was […]

May 3, 2022 Uncategorized

Subgroups of glioblastoma associated with disease prognosis

Researchers have detected different subgroups of the brain tumour form glioblastoma, where the cancer cells’ properties depend on […]

May 2, 2022 Uncategorized

MRI identifies markers of atypical brain development in preterm children

Premature babies who develop abnormalities like autism and cerebral palsy as teenagers have subtle differences in brain structure […]

May 2, 2022 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 30 31
Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy